3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
14
Pancreatic Neoplasms
13
Neoplasm Metastasis
8
Small Cell Lung Carcinoma
4
Neuroblastoma
4
Lung Neoplasms
4
Sarcoma
3
Rhabdomyosarcoma
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Biliary Tract Neoplasms
3
Stomach Neoplasms
2
Sarcoma, Ewing
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Refractory Solid Tumors
1
Recurrence
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
24
Vincristine
17
Prednisone
16
Methotrexate
16
prednylidene
13
merphos
13
deltacortene
13
blinatumomab
13
Specimen Handling
13
Cytarabine
13
pegaspargase
10
N,N-dicyclohexyl-isoborneol-10-sulfonamide
10
Mercaptopurine
10
Doxorubicin
10
Dexamethasone
10
Biopsy
10
azathiopurine
9
Spinal Puncture
9
Etoposide
9
dexamethasone acetate
8
dexamethasone 21-phosphate
8
auricularum
8
Rituximab
8
Leucovorin
8
Calcium Dobesilate
8
venetoclax
7
fludarabine
7
Asparaginase
7
Thioguanine
6
Magnetic Resonance Spectroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
Irinotecan
×
30 days
×
Clear all
No trials found.